Board Appointments

BOARD APPOINTMENTS AT UDG HEALTHCARE PLC

The Board of UDG Healthcare plc (the 'Company') is pleased to announce the appointments of Mr Gerard van Odijk and Ms Linda Wilding as non-executive directors of the Company and Mr Brendan McAtamney as an executive director, with effect from 16 December 2013. Gerard will also join the Risk, Acquisitions & Finance Committee and Linda will join the Audit Committee.

Gerard was President and Chief Executive Officer Europe of Teva Pharmaceuticals until 2012. Prior to this, Gerard held various senior management positions with GlaxoSmithKline, latterly holding the position of Senior Vice President and Area Director Northern Europe. Gerard is currently a non-executive director of Bavarian Nordic A/S is Chairman of Merus Biopharmaceuticals.

Linda's career included twelve years at Mercury Asset Management where she held the position of Managing Director in the Private Equity division. Prior to this, Linda qualified as a chartered accountant while working with Ernst & Young. Linda is currently Chairman of Pacific Direct Limited and Chairman of the Valuation Committee at HgCapital Private Equity and HgCapital Renewable Investments. Linda previously served as Chairman of Corin plc, Chairman of Sanctuary Holdings Limited, and Chairman of Cornish Bakehouse and as a non-executive director of Luminar plc.

Brendan joined the Company in September 2013 as Chief Operating Officer. Previously, he held various senior management positions with Abbott, latterly as Vice President Commercial and Corporate Officer within the Established Pharmaceuticals Division. 

Mr Hugh Friel, who has served on the board since April 2009 has indicated that, for personal reasons, he will not go forward for re-election at the Annual General Meeting in February 2014.

"We are delighted to welcome Gerard, Linda, and Brendan to the board", said chairman, Peter Gray. "Gerard and Brendan bring significant European pharmaceutical industry experience, while Linda brings a London-based financial background. We are sorry to lose Hugh, and thank him for the excellent contribution he has made to our deliberations over the past five years."